RIVN vs TARS · rev $1.66B vs rev $336.0M
Rivian Automotive Inc (RIVN) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
Rivian Automotive Inc (RIVN) is a auto manufacturers company listed on NASDAQ. It is led by Robert Joseph Scaringe Ph.D..
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported RIVN revenue for 2026-06-30 was $1.66B. Net income was -$833.0M. Revenue was up 20.1% from 2026-03-31 to 2026-06-30. RIVN currently screens at market cap $21.81B.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
RIVN currently screens at market cap $21.81B. TARS currently screens at market cap $2.66B.
Not investment advice. Open the RIVN and TARS stock pages for the full models.
Not investment advice.